USTEKINUMAB-TTWE (ustekinumab-ttwe)

**Product type:** Human Prescription Drug

**Active ingredient:** USTEKINUMAB

**Strength:** 45 mg/.5mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Quallent Pharmaceuticals Health LLC

**Marketing category:** BLA (BLA761373)

**Pharmacologic class:** Interleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]